The DNA repair enzyme O6-methylguanine-DNA methyltransferase (MGMT) is commonly overexpressed in cancers and is implicated in the development of chemoresistance.

The use of drugs inhibiting MGMT has been hindered by their haematologic toxicity and inefficiency. As a different strategy to inhibit MGMT authors investigated cellular regulators of MGMT expression in multiple cancers.

Researchers show a significant correlation between Wnt signalling and MGMT expression in cancers with different origin and confirm the findings by bioinformatic analysis and immunofluorescence.

They demonstrate Wnt-dependent MGMT gene expression and cellular co-localization between active β-catenin and MGMT.

Pharmacological or genetic inhibition of Wnt activity downregulates MGMT expression and restores chemosensitivity of DNA-alkylating drugs in mouse models.

These findings have potential therapeutic implications for chemoresistant cancers, especially of brain tumors where the use of temozolomide is frequently used in treatment.

http://www.nature.com/ncomms/2015/151125/ncomms9904/full/ncomms9904.html